It has been shown that when the active disease is not detected on CT or PET/CT scans or biopsies, discontinuing anti-PD-1 therapy after 12 months may result in a lower rate of disease recurrence in patients with advanced melanoma (50). Here, PDCD1 is linked to melanoma.